NIAID Accomplishments

NIAID conducts and supports research to better understand, treat, and ultimately prevent infectious and immune-mediated diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and abroad. This page highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers.

Selected NIAID Research Advances of 2016

This slideshow highlights scientific advances made by NIAID researchers and NIAID-funded scientists in the United States and abroad during fiscal year 2016. Some advances brought us closer to vaccines and treatments for HIV/AIDS, Zika, influenza, and other infectious diseases of global importance. Other developments offered new insights into allergic and autoimmune diseases, and immune responses to infection. View the Selected NIAID Research Advances 2016.

Zika Virus

Selected NIAID Research Advances of 2015

This slideshow highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers at domestic and international institutions during fiscal year 2015. Some advances brought us closer to vaccines and treatments for HIV, influenza, and Ebola. Others offered new insights into food allergy prevention, autoimmune diseases, and drug-resistant infections. View the Selected NIAID Research Advances 2015.

photo of Anthony Fauci

Selected NIAID Research Advances of 2014

This slideshow highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers at domestic and international institutions during fiscal year 2014. All are representative of how public investment in biomedical research can advance science and benefit human health. View the Selected NIAID Research Advances 2014.

photo of Anthony Fauci
Content last reviewed on January 3, 2017